Gene test may help men with prostate cancer avoid unnecessary treatment

NCT ID NCT04396808

First seen Jan 11, 2026 · Last updated May 08, 2026 · Updated 14 times

Summary

This study looks at whether a special gene test can help men with low-risk prostate cancer safely choose active surveillance (watching the cancer closely) instead of immediate treatment like surgery or radiation. About 800 men with early-stage prostate cancer are taking part. The goal is to see if the gene test helps doctors and patients make better decisions about whether treatment is needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Henry Ford Health System

    Detroit, Michigan, 48202, United States

  • Montefiore Medical Center

    The Bronx, New York, 10461, United States

  • Sherwood Medical Center

    Detroit, Michigan, 48221, United States

  • Spectrum Health Medical Group

    Grand Rapids, Michigan, 49503, United States

  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, 48109, United States

  • University of North Carolina

    Chapel Hill, North Carolina, 27599, United States

  • University of Pennsylvania Perelman School of Medicine

    Philadelphia, Pennsylvania, 19104, United States

  • Western Michigan Urological Associates

    Holland, Michigan, 49423, United States

Conditions

Explore the condition pages connected to this study.